ComplyRx
Built by ComplyRx

Compare clinical trial pipelines, export for presentations

dapagliflozin (16) vs empagliflozin (16)16 active2007–2032
dapagliflozinempagliflozin
Key
Actual date
Anticipated
Forecast to primary completion
RecruitingNot yet recruitingCompletedUnknown status
'07
'09
'11
'13
'15
'17
'19
'21
'23
'25
'27
'29
'31
dapagliflozin
A Phase III Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes Who Are Not Well Controlled on Metformin AloneP3
Dapagliflozin DPPIV Inhibitor add-on StudyP3
Effects of Dapagliflozin on Kidney Function (Glomerular Filtration Rate) in Subjects With Type 2 DiabetesP2
Evaluation of Safety and Efficacy of Dapagliflozin in Subjects With Type 2 Diabetes Who Have Inadequate Glycaemic Control on Background Combination of Metformin and SulfonylureaP3
Safety and Efficacy of Saxagliptin in Triple Therapy to Treat Subjects With Type 2 DiabetesP3
Phase III Insulin Add-On Asia Regional Program - STP3
Study to Evaluate Safety and Efficacy of Dapagliflozin and Saxagliptin in Patients With Type 2 Diabetes Mellitus (T2DM) Aged 10 to Below 18 Years OldP3
D3DOSAP3
Effect of Dapagliflozin on Renal Outcomes and Bone Mineral Disease in Non-diabetic Chronic Kidney Disease PatientsP4
ACHIEVE-2P3
SGLT2i to Prevent of Liver Complications in Patients With CHB and Diabetes MellitusP4
Real-World Evaluation of Omarigliptin for Type 2 Diabetes Meliitus in BangladeshP4
STAMI-BASP4
THP-001-031P3
SLGT2i for Neuroprotection in Patients With Acute Ischemic StrokeP3
A Comparison of Effectiveness, Safety, and Cost-effectiveness of Dapagliflozin and Empagliflozin in Patients With Type 2 Diabetes Mellitus and High Body Mass Index (BMI)P4
empagliflozin
Empagliflozin (BI 10773) in Type Two Diabetes (T2D) Patients, Open Label ExtensionP2
Efficacy and Safety of Empagliflozin (BI 10773) Versus Placebo and Sitagliptin Over 24 Weeks in Patients With Type 2 DiabetesP3
ERA-HFP4
EMPA post-GDMP3
RECOVERYP3
Comparison of Empaglifozin and Vildagliptin in Type 2 Diabetes MellitusP4
EMPACT-MI: A Study to Test Whether Empagliflozin Can Lower the Risk of Heart Failure and Death in People Who Had a Heart Attack (Myocardial Infarction)P3
Use of SGLT2i in noHCM With HFpEFP4
EMPA-AHFP3
The Efficacy and Safety of Empagliflozin - Linagliptin and Empagliflozin- Metformin Therapy in Reduction of Body Weight in Type 2 Diabetic Patients .P4
SGLT2i to Prevent of Liver Complications in Patients With CHB and Diabetes MellitusP4
Real-World Evaluation of Omarigliptin for Type 2 Diabetes Meliitus in BangladeshP4
Pioglitazone and Empagliflozin for Fatty Liver Disease in Type 2 DiabetesP4
SLGT2i for Neuroprotection in Patients With Acute Ischemic StrokeP3
A Comparison of Effectiveness, Safety, and Cost-effectiveness of Dapagliflozin and Empagliflozin in Patients With Type 2 Diabetes Mellitus and High Body Mass Index (BMI)P4
EMPASTONEP3

Upcoming readouts

11 ahead · 2 drugs

Select a trial to load its full ClinicalTrials.gov record.

Trial Pipeline · How it works

Search, compare, export.

Three steps from drug name to a presentation-ready pipeline view, with live trial data, side by side.

  1. 01 · SEARCH

    Search drugs

    Type a drug name and see the phase 2-4 trials from ClinicalTrials.gov.

  2. 02 · COMPARE

    Compare timelines

    See start dates, primary completions, and status on one timeline, up to five drugs at once.

  3. 03 · EXPORT

    Export for your deck

    Download a branded PNG or PDF. Share the URL. Every comparison state is linkable.

FAQ

Where does the data come from?
All trial data is sourced from ClinicalTrials.gov (CTGov). Results are cached for up to 6 hours so repeat loads stay fast.
Is this free?
Yes. Compare up to five drugs and export PNG or PDF at no cost. Export requires a one-time email to join the ComplyRx waitlist.
What is ComplyRx?
ComplyRx is an all-in-one marketing/competitive intelligence platform for organisations and individuals that work in healthcare, life sciences, and the pharmaceutical industry.
Join the waitlist

Be the first to access ComplyRx

We'll let you know as soon as your spot opens to use ComplyRx.

By joining, you agree to our Privacy Policy.